trametinib tablets 0.5mg

A highly selective, reversible, small-molecule inhibitor of Mitogen-Activated Extracellular Signal-Regulated Kinase 1 (MEK1) and MEK2. By blocking these proteins, it disrupts the MAPK cell-signaling pathway, halting the unchecked proliferation and survival of tumor cells carrying the BRAF mutation.

Trametinib Tablets 0.5MG
Click to expand
Anti Cancer

trametinib tablets 0.5mg

By NOVARTIS

Our Price

51,195
1
Ask for Quote
WHO-GMP
ISO Certified
Trusted Exporter
Secure Supply

Strength

0.5 MG

Packaging

30 tablets per bottle.

Type

High-Density Polyethylene (HDPE) bottle

Shelf Life

18 to 24 months

A highly selective, reversible, small-molecule inhibitor of Mitogen-Activated Extracellular Signal-Regulated Kinase 1 (MEK1) and MEK2. By blocking these proteins, it disrupts the MAPK cell-signaling pathway, halting the unchecked proliferation and survival of tumor cells carrying the BRAF mutation.

Manufacturer Info

NameNOVARTIS
PrescriptionPrescription

Global Compliance

Our products strictly adhere to International Safety Protocols. 2M Pharmaceuticals ensures 100% genuine supply chain monitoring for all export orders.

Quote
Direct Export Pricing

Ready for Bulk Pharmaceutical Inquiries?

Connect with our dedicated export sales team for competitive quotes and reliable global logistical support.

Contact Sales